Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
NCT00675220
·
clinicaltrials.gov ↗
COMPLETED
Status
373
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Delivery Systems
Interventions
DRUG:
insulin aspart
Sponsor
Novo Nordisk A/S